Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix, NuGen to Co-Market FFPE Sampling and GeneChip Combo

NuGen’s WT-Ovation technology will work with standard Affy 3 prime arrays, not Affy's three-inch arrays.
 
NEW YORK (GenomeWeb News) — Affymetrix today said it and NuGen Technologies will co-market a NuGen product that helps Affy GeneChip customers analyze formalin-fixed, paraffin-embedded tissue samples.
 
Affy said NuGen’s WT-Ovation technology will work with standard Affy 3 prime arrays and will allow researchers to analyze gene expression on “small and degraded” tissue samples.
 
The company said the technology needs 50 nanograms of RNA and can generate “several” micrograms of cDNA in six hours.
 
Affymetrix said the Ovation/GeneChip offering is currently available for sample processing jobs through Expression Analysis, a NuGen and Affymetrix service provider.
 
The WT-Ovation system will be available for sale this week, Affymetrix said.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.